Home › NDC Lookup › RxCUI directory › RxCUI 1552270

Lanolin 0.5 MG/MG Topical Ointment [Lanashield] — RxCUI 1552270

Name: Lanolin 0.5 MG/MG Topical Ointment [Lanashield] (RxCUI 1552270)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1552270 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1552270

Official nameLanolin 0.5 MG/MG Topical Ointment [Lanashield]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asLanashield 50 % Topical Ointment; Lanashield 0.5 MG/MG Topical Ointment

FDA products mapped1

Package NDCs mapped4

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Lanolin 0.5 MG/MG Topical Ointment [Lanashield] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Lanolin 0.5 MG/MG Topical Ointment [Lanashield] RxCUI 1552270 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Lanolin 6227 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Lanashield 1552266 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Lanolin Topical Ointment 605674 SCDF
- Lanolin Topical Product 1162829 SCDG
- Lanolin Topical Ointment [Lanashield] 1552268 SBDF
- Lanashield Topical Product 1552269 SBDG
- Topical Ointment 316985 DF
- Topical Product 1151122 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Lanolin 0.5 MG/MG Topical Ointment 853167 SCD
- Lanolin 0.5 MG/MG 853166 SCDC
- Lanolin 0.5 MG/MG [Lanashield] 1552267 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Lanolin 0.5 MG/MG Topical Ointment SCD · 853167
Lanolin 0.5 MG/MG SCDC · 853166
Lanolin Topical Ointment SCDF · 605674
Lanolin Topical Product SCDG · 1162829

Brand-Name Concepts

Lanolin 0.5 MG/MG [Lanashield] SBDC · 1552267
Lanolin Topical Ointment [Lanashield] SBDF · 1552268
Lanashield Topical Product SBDG · 1552269
Lanashield BN · 1552266

📦 FDA Products & Package NDCs

1 product · 4 package NDCs

4 package NDCs map to RxCUI 1552270 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
67777-0410-03	24 TUBE in 1 CASE (67777-410-03) / 113 g in 1 TUBE (67777-4...	Lanashield	Dynarex Corporation	2014-10-12
67777-0410-07	2 BOX in 1 CASE (67777-410-07) / 144 PACKET in 1 BOX (67777...	Lanashield	Dynarex Corporation	2014-10-12
67777-0410-12	36 JAR in 1 CASE (67777-410-12) / 71 g in 1 JAR (67777-410-...	Lanashield	Dynarex Corporation	2014-10-12
67777-0410-14	12 JAR in 1 CASE (67777-410-14) / 397 g in 1 JAR (67777-410...	Lanashield	Dynarex Corporation	2014-10-12

Observed labelers: Dynarex Corporation (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.